Safety and efficacy of convalescent plasma for COVID-19: the preliminary results of a clinical trial

Safety and efficacy of convalescent plasma for COVID-19: the preliminary results of a clinical trial

Background. The lack of effective etiotropic therapy for COVID-19 has prompted researchers around the globe to seekr various methods of SARS-CoV-2 elimination, including the use of convalescent plasma. Aim. The aim of this work was to study the safety and efficacy of the convalescence plasma trea...

Full description

Bibliographic Details
Main Authors: Vladimir P. Baklaushev, Alexander V. Averyanov, Anna G. Sotnikova, Anastasia S. Perkina, Alexander V. Ivanov, Gaukhar M. Yusubalieva, Oksana N. Novikova, Valentina E. Shikina, Nikolay V. Dupik, Anna G. Kedrova, Andrey E. Sanzharov, Elena V. Shirshova, Olga I. Balionis, Vladimir T. Valuev-Elliston, Natalia F. Zakirova, Yaroslav N. Glazov, Irina A. Panukhina, Nikolay A. Soloviev, Alexei G. Vinokurov, Yu. V. Ivanov, Valentin N. Vasilev, Tatyana V. Klypa, Alexander V. Troitsky
Format: Article
Language:Russian
Published: Eco-vector 2020-08-01
Series:Клиническая практика
Subjects:
sars-cov-2
covid-19
plasma of convalescents
antibodies to rbd s-protein
ards
mechanical ventilation
Online Access:https://journals.eco-vector.com/clinpractice/article/viewFile/35168/pdf

Internet

https://journals.eco-vector.com/clinpractice/article/viewFile/35168/pdf

Similar Items